Drug Shortage Report for 20% PROSOL
| Report ID | 247510 |
| Drug Identification Number | 02141450 |
| Brand name | 20% PROSOL |
| Common or Proper name | 20% Prosol- Sulfite-Free (Amino Acid) |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | TYROSINE L-ASPARTIC ACID SERINE GLUTAMIC ACID PROLINE ARGININE GLYCINE ALANINE TRYPTOPHAN DL-METHIONINE THREONINE PHENYLALANINE LEUCINE ISOLEUCINE HISTIDINE LYSINE VALINE |
| Strength(s) | 0.05G 0.6G 1.02G 1.02G 1.34G 1.96G 2.06G 2.76G 0.32G 0.76G 0.98G 1G 1.08G 1.08G 1.18G 1.35G 1.44G |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 6 ea/ca |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-01-08 |
| Actual start date | 2025-01-08 |
| Estimated end date | 2025-02-03 |
| Actual end date | 2025-02-06 |
| Shortage status | Resolved |
| Updated date | 2025-02-07 |
| Company comments | Indirect substitute: JB6583 TRAVASOL 10% W/O LYTES 3000 ML and JB6584 TRAVASOL 10% W/O LYTES 1000 ML The composition of each product/comparison of the amino acid profiles would need to be shared with end users. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-02-07 | French | Compare |
| v6 | 2025-02-07 | English | Compare |
| v5 | 2025-01-27 | French | Compare |
| v3 | 2025-01-27 | English | Compare |
| v4 | 2025-01-27 | English | Compare |
| v2 | 2025-01-13 | French | Compare |
| v1 | 2025-01-13 | English | Compare |
Showing 1 to 7 of 7